ukmla MCQ (SBA): NSTE-ACS antiplatelet therapy

Instant feedback + full explanation. One question, done properly.

MediumCardiologyNSTE-ACS antiplatelet therapyukmlamrcp part 1mrcem sbapaneprescribing safety assessment

A 60-year-old man with NSTEMI is to receive dual antiplatelet therapy. He is not at high bleeding risk and no indication for anticoagulation. Which combination is recommended?

Educational content. Not a substitute for clinical judgement or local policy.

ukmla MCQ: NSTE-ACS antiplatelet therapy — Answer & Explanation | iatr